Work

INSPIRE: A Phase 3 Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension (PAH) (Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil NCT03399604)

Year: 2019

Type: article

Source: The Journal of Heart and Lung Transplantation

DOI: 10.1016/j.healun.2019.01.011

Authors: N.S. Hill, J.P. Feldman, S. Sahay, D.J. Levine, R.F. Roscigno, T.A. Vaughn, T.M. Bull

Institutions: Tufts Medical Center, Houston Methodist, Weill Cornell Medicine, The University of Texas at San Antonio Health Science Center, Liquidia Technologies (United States), University of Colorado Anschutz, University of Colorado Denver

Language: English

Topic: Inhalation and Respiratory Drug Delivery

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2920936408

FWCI: 1.444

Cites:

Cited by: 8

Related to: 10